Feinstein Institutes Researchers Discover the Brain’s Respiratory Alarm Mechanism Researchers at Northwell Health’s Feinstein Institutes for Medical Research have uncovered a previously unknown brain circuit that continuously monitors every breath we take, providing new insights into how humans consciously detect…
PK MED Strengthens Leadership and Scientific Governance to Advance ARTHRELIS and ENGRAFTIS Development Programs PK MED, a French biotechnology company established by healthcare investment firm Truffle Capital, has announced a significant expansion of its corporate governance with the appointment of…
Niagen Bioscience Publishes New Research Linking Niagen® Supplementation to Reduced Biological Aging in Skeletal Muscle Niagen Bioscience, Inc., a global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy aging research, has announced the publication of a new peer-reviewed study…
Precision BioSciences Strengthens Executive Leadership to Support Clinical Growth and Advance Gene Editing Pipeline Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical-stage gene editing company focused on developing transformative in vivo gene editing therapies for serious diseases with significant unmet medical…
Yarrow Bioscience Completes Merger with VYNE Therapeutics and Secures Approximately $200 Million to Advance First-in-Class Autoimmune Thyroid Disease Program Yarrow Bioscience, Inc., a clinical-stage biotechnology company dedicated to developing innovative therapies for autoimmune thyroid diseases, has announced the successful completion…
Aptar Pharma’s Nanopharm Facility Earns MHRA GMP Certification, Strengthening Global Support for Inhaled and Nasal Drug Development Aptar Pharma, a global leader in drug delivery systems, dosing technologies, protection solutions, and pharmaceutical development services, has announced that its Nanopharm facility…
Cancer Cell Diagnostics Launches CellSight™ DNA Comprehensive Genomic Profiling Test to Advance Precision Oncology Cancer Cell Diagnostics (CCDx) has announced the commercial launch of CellSight™ DNA, its next-generation comprehensive genomic profiling (CGP) assay designed to provide oncologists with a broader…
Seek Labs Publishes Nature Communications Study Showcasing ANINA™ Technology for Next-Generation Molecular Diagnostics Seek Labs, a private TechBio company focused on developing programmable technologies to decode, understand, and treat disease, has announced the publication of a peer-reviewed research paper in…
FUJIFILM Sonosite Launches Sonosite iLOOK, a Dedicated Ultrasound Solution Designed to Enhance Vascular Access Procedures FUJIFILM Sonosite, Inc., a global leader in point-of-care ultrasound (POCUS) technology, has announced the introduction of Sonosite iLOOK, a compact ultrasound solution specifically engineered to…
Kinaset Therapeutics Doses First Patient in Phase 2b Trial of Frevecitinib for Severe Asthma Kinaset Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative inhaled therapies for serious respiratory diseases, has announced the dosing of the first patient in its…
iVeena Delivery Systems Completes Phase 1 Trial of IVMED-85, Advancing Novel Eye Drop Therapy for Pediatric Myopia iVeena Delivery Systems, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing innovative therapies for eye diseases, has announced the successful completion of…
Veradermics Presents New Phase 2/3 Data Highlighting the Potential of VDPHL01 for Male Pattern Hair Loss Across Age Groups Veradermics, Incorporated, a late-stage biopharmaceutical company founded by dermatologists and dedicated to developing innovative therapies for pattern hair loss, has announced…